Ultragenyx PharmaceuticalRARE
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 303 institutions reported holding Ultragenyx Pharmaceutical Inc. (RARE) in their 13F filings, down 7 from Q2 2025. 50 opened new positions and 56 sold out. The largest holders were Vanguard Group Inc. ($304.8M), FMR LLC ($219.1M) and BlackRock, Inc. ($193.3M). 7 famous investors held it, including Cliff Asness (0.0% of AQR Capital Management's portfolio), Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ultragenyx Pharmaceutical Inc.
- CUSIP
- 90400D108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 50 | $88.7M |
| Exits | 56 | $241.2M |
All 13F filers, Q2 2025 → Q3 2025: 22,273,079 shares bought and 20,359,904 shares sold, net +1,913,175 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 303 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.8% | 10,132,728 | $304.8M |
| FMR LLC | 0.01% | Add +179.6% | 7,283,296 | $219.1M |
| BlackRock, Inc. | 0.00% | Add +2.7% | 6,425,263 | $193.3M |
| JPMorgan Chase & Co. | 0.01% | Add +23.0% | 4,011,429 | $120.7M |
| Sands Capital Management, LLC | 0.31% | Reduce -4.4% | 3,769,853 | $113.4M |
| State Street Corp. | 0.00% | Add +43.5% | 3,692,487 | $111.1M |
| RTW Investments, LP | 1.21% | Add +90.8% | 3,258,266 | $98.0M |
| Baker Bros. Advisors LP | 0.60% | No change | 2,772,692 | $83.4M |
| T. Rowe Price Associates Inc. | 0.01% | Reduce -20.0% | 2,310,174 | $69.5M |
| Jacobs Levy Equity Management, Inc. | 0.26% | Add +614.1% | 2,167,729 | $65.2M |
| Montanova Capital, LLC | 1.84% | Reduce -11.4% | 2,019,000 | $60.7M |
| Wellington Management Group LLP | 0.01% | Add +3.9% | 1,945,129 | $58.5M |
| Geode Capital Management, LLC | 0.00% | Reduce -7.7% | 1,580,507 | $47.6M |
| Deutsche Bank AG | 0.02% | Reduce -7.2% | 1,546,101 | $46.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.12% | Add +6.4% | 1,545,279 | $46.5M |
| Pictet Asset Management Holding SA | 0.04% | Reduce -14.2% | 1,458,187 | $44.0M |
| Rock Springs Capital Management LP | 2.20% | Reduce -10.4% | 1,246,341 | $37.5M |
| GW&K Investment Management, LLC | 0.31% | Add +139.0% | 1,150,169 | $34.6M |
| Schonfeld Strategic Advisors LLC | 0.24% | Add +101.8% | 1,144,589 | $34.4M |
| Frontier Capital Management Co. LLC | 0.29% | Add +103.5% | 1,069,098 | $32.2M |
| Frazier Life Sciences Management, L.P. | 0.89% | No change | 983,715 | $29.6M |
| Aberdeen Group plc | 0.05% | Add +94.3% | 973,656 | $29.3M |
| Morgan Stanley | 0.00% | Add +42.5% | 910,183 | $27.4M |
| Russell Investments Group, Ltd. | 0.03% | Add +599.2% | 840,451 | $25.3M |
| Invesco Ltd. | 0.00% | Add +9.8% | 794,849 | $23.9M |
| Candriam S.C.A. | 0.12% | Add +43.4% | 754,714 | $22.7M |
| Vestal Point Capital, LP | 1.02% | New | 750,000 | $22.6M |
| AQR Capital Management | 0.01% | Add +195.7% | 746,182 | $22.4M |
| Eagle Health Investments LP | 5.50% | Add +11.1% | 697,000 | $21.0M |
| Nuveen, LLC | 0.01% | Add +35.0% | 682,144 | $20.5M |
| Franklin Resources Inc. | 0.01% | Add +42.5% | 677,184 | $20.4M |
| Bank of America Corp. | 0.00% | Add +2.7% | 655,021 | $19.7M |
| Driehaus Capital Management LLC | 0.13% | Reduce -0.5% | 603,397 | $18.2M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -2.6% | 600,160 | $18.1M |
| Braidwell LP | 0.72% | New | 588,700 | $17.7M |
| Polar Capital Holdings Plc | 0.09% | Add +5.9% | 583,710 | $17.6M |
| BNP Paribas Financial Markets | 0.01% | Add +153.7% | 573,019 | $17.2M |
| UBS Group AG | 0.00% | Add +24.2% | 547,025 | $16.5M |
| Alyeska Investment Group, L.P. | 0.05% | Reduce -62.8% | 531,996 | $16.0M |
| Two Sigma Advisers, LP | 0.03% | Reduce -39.8% | 517,700 | $15.6M |
| Massachusetts Financial Services Co. | 0.00% | Add +3.0% | 501,163 | $15.1M |
| Northern Trust Corp. | 0.00% | Add +1.2% | 499,232 | $15.0M |
| Federated Hermes, Inc. | 0.03% | Reduce -75.8% | 496,060 | $14.9M |
| Voloridge Investment Management, LLC | 0.05% | New | 482,582 | $14.5M |
| Goldman Sachs Group Inc. | 0.00% | Add +12.0% | 476,938 | $14.3M |
| Fred Alger Management, LLC | 0.05% | Add +4.3% | 448,717 | $13.5M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | Reduce -71.9% | 430,000 | $12.9M |
| Barclays PLC | 0.00% | Add +138.1% | 425,351 | $12.8M |
| Blue Owl Capital Holdings LP | 3.97% | Add +65.5% | 422,438 | $12.7M |
| Emerald Advisers, LLC | 0.40% | Reduce -9.3% | 418,566 | $12.6M |
| AXA Investment Managers S.A. | 0.03% | — | 417,198 | $12.5M |
| Legal & General Group Plc | 0.00% | Add +28.4% | 402,815 | $12.1M |
| MPM Bioimpact LLC | 1.95% | No change | 395,700 | $11.9M |
| Palo Alto Investors LP | 2.06% | Add +658.0% | 369,531 | $11.1M |
| Motley Fool Wealth Management, LLC | 0.73% | Add +29.3% | 355,540 | $10.7M |
| Jane Street Group, LLC | 0.01% | Add +217.0% | 354,168 | $10.7M |
| Sphera Funds Management LTD. | 2.52% | Add +252.3% | 352,558 | $10.6M |
| Manufacturers Life Insurance Company, The | 0.01% | Reduce -11.7% | 344,923 | $10.4M |
| Citadel Advisors | 0.01% | Add +779.6% | 330,953 | $10.0M |
| Two Sigma Investments, LP | 0.02% | Reduce -43.5% | 326,180 | $9.8M |
| Bank of New York Mellon Corp | 0.00% | Reduce -31.4% | 324,845 | $9.8M |
| Algert Global LLC | 0.16% | Add +176.4% | 321,633 | $9.7M |
| Victory Capital Management Inc. | 0.01% | Reduce -28.1% | 298,891 | $9.0M |
| Catalio Capital Management, LP | 1.62% | Add +36.5% | 291,262 | $8.8M |
| WCM Investment Management, LLC | 0.02% | Add +36.9% | 288,109 | $8.7M |
| Privium Fund Management B.V. | 1.57% | Add +14.4% | 289,804 | $8.7M |
| First Light Asset Management, LLC | 0.81% | Reduce -47.9% | 285,699 | $8.6M |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.01% | Reduce -9.8% | 280,466 | $8.4M |
| Woodline Partners LP | 0.04% | No change | 273,251 | $8.2M |
| Moore Capital Management, LP | 0.17% | Reduce -6.9% | 270,000 | $8.1M |
| Hudson Bay Capital Management LP | 0.06% | Add +2.4% | 265,000 | $8.0M |
| Assenagon Asset Management S.A. | 0.01% | Reduce -78.3% | 252,669 | $7.6M |
| Emerald Mutual Fund Advisers Trust | 0.38% | Reduce -17.8% | 242,802 | $7.3M |
| D. E. Shaw & Co. | 0.01% | Reduce -56.1% | 237,640 | $7.1M |
| Royal Bank of Canada | 0.00% | Add +2252.8% | 236,289 | $7.1M |
| Susquehanna International Group, LLP | 0.01% | Add +191.8% | 234,126 | $7.0M |
| Yiheng Capital Management, L.P. | 2.25% | New | 225,758 | $6.8M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -31.2% | 207,042 | $6.2M |
| Macquarie Group Ltd. | 0.01% | Reduce -14.6% | 200,717 | $6.0M |
| Los Angeles Capital Management LLC | 0.02% | New | 194,982 | $5.9M |
| Aquatic Capital Management LLC | 0.11% | Add +79.1% | 191,458 | $5.8M |
| Sei Investments Co. | 0.01% | Add +111.2% | 190,462 | $5.7M |
| Ensign Peak Advisors, Inc | 0.01% | Add +391.9% | 177,421 | $5.3M |
| Capital Fund Management S.A. | 0.05% | Add +92.5% | 177,061 | $5.3M |
| Cubist Systematic Strategies, LLC | 0.07% | Add +102.5% | 172,674 | $5.2M |
| Fisher Asset Management | 0.00% | Reduce -9.5% | 168,084 | $5.1M |
| Swiss National Bank | 0.00% | Add +2.4% | 164,952 | $5.0M |
| Caption Management, LLC | 0.30% | Reduce -30.7% | 164,501 | $4.9M |
| PDT Partners, LLC | 0.30% | No change | 156,693 | $4.7M |
| Rafferty Asset Management, LLC | 0.02% | Add +93.0% | 156,484 | $4.7M |
| Clearbridge Investments, LLC | 0.00% | Reduce -92.7% | 155,752 | $4.7M |
| Trexquant Investment LP | 0.05% | Reduce -33.9% | 155,388 | $4.7M |
| Schroder Investment Management Group | 0.00% | Reduce -55.2% | 150,571 | $4.6M |
| Marshall Wace, LLP | 0.00% | Add +121.8% | 146,094 | $4.4M |
| Ameriprise Financial Inc. | 0.00% | Add +27.0% | 138,684 | $4.2M |
| B Group, Inc. | 4.06% | Add +22.7% | 135,000 | $4.1M |
| Squarepoint Ops LLC | 0.01% | Add +516.9% | 133,772 | $4.0M |
| EFG Asset Management (North America) Corp. | 0.50% | Reduce -5.8% | 127,985 | $3.8M |
| SG Americas Securities, LLC | 0.01% | New | 125,429 | $3.8M |
| Gilder Gagnon Howe & Co. LLC | 0.04% | Reduce -1.0% | 121,941 | $3.7M |
"% of holder's portfolio" is RARE's weight in each manager's 13F, not the share of Ultragenyx Pharmaceutical Inc. the manager owns.